Medtronic (MDT) Research & Development (2014 - 2026)

Medtronic (MDT) has 13 years of Research & Development data on file, last reported at $671.0 million in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 1.9% year-over-year to $671.0 million; the trailing twelve-month figure through Apr 2026 stood at $2.9 billion (up 5.16% YoY), and the FY2026 full-year result was $2.9 billion, up 5.16% from the prior year.
• Research & Development retreated to $671.0 million in Q2 2026, from $722.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $754.0 million in Q4 2025 to a low of $641.0 million in Q2 2023.
• A 5-year average of $686.6 million and a median of $680.0 million in 2022 frame the typical range for Research & Development.
• Peak annual rise in Research & Development reached 11.15% in 2022, while the deepest fall reached 7.73% in 2022.
• Tracing MDT's Research & Development over 5 years: stood at $676.0 million in 2022, then increased by 3.25% to $698.0 million in 2023, then dropped by 0.14% to $697.0 million in 2024, then gained by 8.18% to $754.0 million in 2025, then decreased by 11.01% to $671.0 million in 2026.
• Business Quant data shows MDT's Research & Development at $671.0 million in Q2 2026, $722.0 million in Q1 2026, and $754.0 million in Q4 2025.